DRTS
Alpha Tau Medical Ltd.
Price Chart
Latest Quote
$9.78
+0.17 (+1.77%)
Current Price
| Previous Close | $9.61 |
| Open | $9.75 |
| Day High | $10.20 |
| Day Low | $9.45 |
| Volume | 574,439 |
Stock Information
| Shares Outstanding | 90.33M |
| Total Debt | $14.34M |
| Cash Equivalents | $76.42M |
| Net Income | $-56.88M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $883.39M |
| EPS (TTM) | $-0.67 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $819.84M |
| Income | $-56.88M |
| Book/sh | $0.77 |
| Cash/sh | $0.85 |
| Employees | 121 |
Financial Ratios
| Quick Ratio | 7.31 |
| Current Ratio | 7.79 |
| Debt/Eq | 20.68 |
Returns & Margins
| ROA | -30.50% |
| ROE | -90.51% |
Ownership
| Insider Ownership | 31.23% |
| Institutional Ownership | 4.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -19.00 |
| P/B | 12.72 |
Analyst Data
| Recommendation | buy |
| Target Price | $14.20 |
Technical Indicators
| SMA20 | $9.85 |
| SMA50 | $9.04 |
| SMA200 | $6.33 |
| RSI | 41.96 |
| ATR | 0.8771 |
| Shares Float | 61.83M |
| Short Float | 2.88% |
| Short Ratio | 1.75 |
| Volatility | 1.20 |
| Rel Volume | 0.58 |
Performance History
| Week | +1.03% |
| Month | -8.43% |
| Quarter | +33.61% |
| 6 Months | +90.27% |
| YTD | +102.48% |
| Year | +230.41% |
| 3 Years | +142.08% |
| 5 Years | +1.29% |
| 10 Years | -3.17% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $9.78 | 574,400 |
| 2026-06-17 | $9.61 | 482,300 |
| 2026-06-16 | $9.35 | 370,000 |
| 2026-06-15 | $9.67 | 668,500 |
| 2026-06-12 | $9.85 | 857,400 |
| 2026-06-11 | $9.68 | 700,800 |
| 2026-06-10 | $9.24 | 409,100 |
| 2026-06-09 | $9.19 | 767,500 |
| 2026-06-08 | $9.28 | 598,300 |
| 2026-06-05 | $9.35 | 1,390,500 |
| 2026-06-04 | $10.29 | 1,477,000 |
| 2026-06-03 | $10.58 | 3,237,500 |
| 2026-06-02 | $8.93 | 1,085,200 |
| 2026-06-01 | $9.66 | 1,968,300 |
| 2026-05-29 | $10.83 | 1,454,400 |
| 2026-05-28 | $10.13 | 906,700 |
| 2026-05-27 | $10.29 | 365,400 |
| 2026-05-26 | $10.37 | 796,300 |
| 2026-05-22 | $10.04 | 856,300 |
| 2026-05-21 | $10.96 | 731,700 |
| 2026-05-20 | $11.18 | 1,251,700 |
| 2026-05-19 | $10.68 | 1,005,600 |
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
đ° Latest News
DRTS Stock Shot Up A Whopping 22% Today â Why A $196.5M Prostate Cancer Deal Got Investors Buzzing
Stocktwits âĸ 2026-06-03T14:52:32Z
Alpha Tau Medical Sets Up Catalyst-Rich 2026 as Key Cancer Trial Data Nears
MarketBeat âĸ 2026-05-29T13:03:33Z
Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study
MarketBeat âĸ 2026-05-11T14:07:22Z
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased
MarketBeat âĸ 2026-03-19T15:47:19Z
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
TipRanks âĸ 2026-02-25T15:30:12Z
New Strong Sell Stocks for January 27th
Zacks âĸ 2026-01-27T09:02:00Z
New Strong Sell Stocks for January 20th
Zacks âĸ 2026-01-20T14:12:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $347,000 | $303,000 | $75,000 | $0 |
| Total Expenses | $42,288,000 | $36,042,000 | $35,680,000 | $32,136,000 |
| Other Income Expense | $-3,636,000 | $365,000 | $1,823,000 | $-3,375,000 |
| Net Non Operating Interest Income Expense | $3,418,000 | $3,933,000 | $4,716,000 | $1,769,000 |
| Total Other Finance Cost | $72,000 | $41,000 | $39,000 | $21,000 |
| Interest Expense Non Operating | $347,000 | $303,000 | $75,000 | $0 |
| Operating Expense | $42,288,000 | $36,042,000 | $35,680,000 | $32,136,000 |
| Selling And Marketing Expense | $1,860,000 | $2,349,000 | $1,924,000 | $974,000 |
| General And Administrative Expense | $8,363,000 | $6,673,000 | $7,332,000 | $10,272,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Net Interest Income | $3,418,000 | $3,933,000 | $4,716,000 | $1,769,000 |
| Interest Income | $3,837,000 | $4,277,000 | $4,830,000 | $1,790,000 |
| Normalized Income | $-39,827,280 | $-32,031,050 | $-30,560,710 | $-31,163,250 |
| Net Income From Continuing And Discontinued Operation | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Total Operating Income As Reported | $-42,288,000 | $-36,042,000 | $-35,680,000 | $-32,136,000 |
| Net Income Common Stockholders | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Net Income | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Net Income Including Noncontrolling Interests | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Net Income Continuous Operations | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Pretax Income | $-42,506,000 | $-31,744,000 | $-29,141,000 | $-33,742,000 |
| Interest Income Non Operating | $3,837,000 | $4,277,000 | $4,830,000 | $1,790,000 |
| Operating Income | $-42,288,000 | $-36,042,000 | $-35,680,000 | $-32,136,000 |
| Per Share | ||||
| Diluted EPS | $-0.53 | $-0.45 | $-0.42 | $-0.53 |
| Basic EPS | $-0.53 | $-0.45 | $-0.42 | $-0.53 |
| Other | ||||
| Tax Effect Of Unusual Items | $-836,280 | $83,950 | $419,290 | $-776,250 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-37,291,000 | $-30,704,000 | $-29,815,000 | $-29,388,000 |
| Total Unusual Items | $-3,636,000 | $365,000 | $1,823,000 | $-3,375,000 |
| Total Unusual Items Excluding Goodwill | $-3,636,000 | $365,000 | $1,823,000 | $-3,375,000 |
| Reconciled Depreciation | $1,232,000 | $1,102,000 | $1,074,000 | $979,000 |
| EBITDA (Bullshit earnings) | $-40,927,000 | $-30,339,000 | $-27,992,000 | $-32,763,000 |
| EBIT | $-42,159,000 | $-31,441,000 | $-29,066,000 | $-33,742,000 |
| Diluted Average Shares | $80,581,440 | $69,927,566 | $69,377,922 | $63,534,875 |
| Basic Average Shares | $80,581,440 | $69,927,566 | $69,377,922 | $63,534,875 |
| Diluted NI Availto Com Stockholders | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
| Tax Provision | $121,000 | $6,000 | $16,000 | $20,000 |
| Gain On Sale Of Security | $-3,636,000 | $365,000 | $1,823,000 | $-3,375,000 |
| Research And Development | $32,065,000 | $27,020,000 | $26,424,000 | $20,890,000 |
| Selling General And Administration | $10,223,000 | $9,022,000 | $9,256,000 | $11,246,000 |
| Other Gand A | $8,363,000 | $6,673,000 | $7,332,000 | $10,272,000 |
| Minority Interests | - | - | - | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $77,099,000 | $62,666,000 | $84,475,000 | $105,657,000 |
| Total Assets | $105,652,000 | $86,204,000 | $107,388,000 | $120,149,000 |
| Total Non Current Assets | $27,354,000 | $21,975,000 | $21,632,000 | $13,672,000 |
| Non Current Prepaid Assets | $479,000 | $432,000 | $471,000 | $391,000 |
| Current Assets | $78,298,000 | $64,229,000 | $85,756,000 | $106,477,000 |
| Restricted Cash | $3,777,000 | $3,255,000 | $3,152,000 | $850,000 |
| Prepaid Assets | $1,059,000 | $1,042,000 | $472,000 | $784,000 |
| Receivables | $336,000 | $332,000 | $344,000 | $313,000 |
| Other Receivables | $336,000 | $332,000 | $344,000 | $313,000 |
| Cash Cash Equivalents And Short Term Investments | $73,126,000 | $59,600,000 | $81,788,000 | $104,530,000 |
| Cash And Cash Equivalents | $12,202,000 | $13,724,000 | $12,657,000 | $5,836,000 |
| Debt | ||||
| Total Debt | $13,726,000 | $12,536,000 | $13,276,000 | $5,193,000 |
| Long Term Debt And Capital Lease Obligation | $12,595,000 | $11,525,000 | $12,214,000 | $4,524,000 |
| Long Term Debt | $6,352,000 | $5,561,000 | $5,610,000 | - |
| Current Debt And Capital Lease Obligation | $1,131,000 | $1,011,000 | $1,062,000 | $669,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $28,553,000 | $23,538,000 | $22,913,000 | $14,492,000 |
| Total Non Current Liabilities Net Minority Interest | $18,046,000 | $14,863,000 | $15,811,000 | $10,154,000 |
| Derivative Product Liabilities | $5,354,000 | $3,338,000 | $3,597,000 | $5,630,000 |
| Non Current Deferred Liabilities | $97,000 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $97,000 | $0 | - | - |
| Current Liabilities | $10,507,000 | $8,675,000 | $7,102,000 | $4,338,000 |
| Payables And Accrued Expenses | $7,652,000 | $6,146,000 | $4,881,000 | $2,762,000 |
| Payables | $3,868,000 | $3,531,000 | $2,645,000 | $1,486,000 |
| Accounts Payable | $3,868,000 | $3,531,000 | $2,566,000 | $1,423,000 |
| Other Payable | - | - | - | $63,000 |
| Equity | ||||
| Common Stock Equity | $77,099,000 | $62,666,000 | $84,475,000 | $105,657,000 |
| Total Equity Gross Minority Interest | $77,099,000 | $62,666,000 | $84,475,000 | $105,657,000 |
| Stockholders Equity | $77,099,000 | $62,666,000 | $84,475,000 | $105,657,000 |
| Retained Earnings | $-190,136,000 | $-147,509,000 | $-115,759,000 | $-86,602,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $88,009,737 | $70,380,570 | $69,670,612 | $69,105,000 |
| Share Issued | $88,009,737 | $70,380,570 | $69,670,612 | $69,105,000 |
| Tangible Book Value | $77,099,000 | $62,666,000 | $84,475,000 | $105,657,000 |
| Invested Capital | $83,451,000 | $68,227,000 | $90,085,000 | $105,657,000 |
| Working Capital | $67,791,000 | $55,554,000 | $78,654,000 | $102,139,000 |
| Capital Lease Obligations | $7,374,000 | $6,975,000 | $7,666,000 | $5,193,000 |
| Total Capitalization | $83,451,000 | $68,227,000 | $90,085,000 | $105,657,000 |
| Additional Paid In Capital | $267,235,000 | $210,175,000 | $200,234,000 | $192,259,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $6,243,000 | $5,964,000 | $6,604,000 | $4,524,000 |
| Current Capital Lease Obligation | $1,131,000 | $1,011,000 | $1,062,000 | $669,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,724,000 | $1,518,000 | $1,159,000 | $907,000 |
| Current Accrued Expenses | $3,784,000 | $2,615,000 | $2,236,000 | $1,276,000 |
| Net PPE | $26,875,000 | $21,543,000 | $21,161,000 | $13,281,000 |
| Accumulated Depreciation | $-5,273,000 | $-4,053,000 | $-2,965,000 | $-1,891,000 |
| Gross PPE | $32,148,000 | $25,596,000 | $24,126,000 | $15,172,000 |
| Construction In Progress | $0 | $1,998,000 | $0 | - |
| Other Properties | $26,043,000 | $17,488,000 | $18,065,000 | $14,579,000 |
| Machinery Furniture Equipment | $854,000 | $859,000 | $813,000 | $593,000 |
| Land And Improvements | $5,251,000 | $5,251,000 | $5,248,000 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $60,924,000 | $45,876,000 | $69,131,000 | $98,694,000 |
| Dueto Related Parties Current | - | $118,000 | $79,000 | $63,000 |
| Treasury Shares Number | - | - | $0 | - |
| Preferred Stock | - | - | $0 | $0 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-32,756,000 | $-22,021,000 | $-24,359,000 | $-24,783,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-26,681,000 | $-19,783,000 | $-17,958,000 | $-23,879,000 |
| Cash Flow From Continuing Operating Activities | $-26,681,000 | $-19,783,000 | $-17,958,000 | $-23,879,000 |
| Operating Gains Losses | $2,051,000 | $-259,000 | $-2,033,000 | $3,788,000 |
| Investing Activities | ||||
| Capital Expenditure | $-6,075,000 | $-2,238,000 | $-6,401,000 | $-904,000 |
| Investing Cash Flow | $-20,588,000 | $20,768,000 | $18,682,000 | $-89,936,000 |
| Cash Flow From Continuing Investing Activities | $-20,588,000 | $20,768,000 | $18,682,000 | $-89,936,000 |
| Net Other Investing Changes | - | $-103,000 | $-3,152,000 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $45,496,000 | $0 | $0 | $0 |
| Financing Cash Flow | $45,768,000 | $25,000 | $5,297,000 | $96,905,000 |
| Cash Flow From Continuing Financing Activities | $45,768,000 | $25,000 | $5,297,000 | $96,905,000 |
| Net Common Stock Issuance | $45,496,000 | $0 | $0 | - |
| Common Stock Issuance | $45,496,000 | $0 | $0 | - |
| Net Other Financing Charges | - | - | - | $93,543,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-5,152,000 | $0 | $0 | - |
| Issuance Of Debt | $5,152,000 | $0 | $5,248,000 | $0 |
| Interest Paid Supplemental Data | $381,000 | $321,000 | $52,000 | $0 |
| Income Tax Paid Supplemental Data | $4,000 | $5,000 | $16,000 | $8,000 |
| End Cash Position | $12,202,000 | $13,724,000 | $12,657,000 | $6,686,000 |
| Beginning Cash Position | $13,724,000 | $12,657,000 | $6,686,000 | $23,854,000 |
| Effect Of Exchange Rate Changes | $-21,000 | $57,000 | $-50,000 | $-258,000 |
| Changes In Cash | $-1,501,000 | $1,010,000 | $6,021,000 | $-16,910,000 |
| Proceeds From Stock Option Exercised | $272,000 | $25,000 | $49,000 | $3,362,000 |
| Net Issuance Payments Of Debt | $0 | $0 | $5,248,000 | $0 |
| Net Short Term Debt Issuance | $0 | $0 | $0 | - |
| Short Term Debt Payments | $-5,152,000 | $0 | $0 | - |
| Short Term Debt Issuance | $5,152,000 | $0 | $0 | - |
| Net Long Term Debt Issuance | $0 | $0 | $5,248,000 | $0 |
| Long Term Debt Issuance | $0 | $0 | $5,248,000 | $0 |
| Net Investment Purchase And Sale | $-14,513,000 | $23,109,000 | $28,235,000 | $-89,032,000 |
| Sale Of Investment | $55,977,000 | $148,191,000 | $191,864,000 | $32,105,000 |
| Purchase Of Investment | $-70,490,000 | $-125,082,000 | $-163,629,000 | $-121,137,000 |
| Net PPE Purchase And Sale | $-6,075,000 | $-2,238,000 | $-6,401,000 | $-904,000 |
| Purchase Of PPE | $-6,075,000 | $-2,238,000 | $-6,401,000 | $-904,000 |
| Change In Working Capital | $2,291,000 | $1,168,000 | $2,492,000 | $-307,000 |
| Change In Other Working Capital | $97,000 | - | - | - |
| Change In Other Current Liabilities | $-23,000 | $-726,000 | $-809,000 | $-1,152,000 |
| Change In Other Current Assets | $817,000 | $789,000 | $729,000 | $535,000 |
| Change In Payables And Accrued Expense | $1,468,000 | $1,624,000 | $2,371,000 | $-986,000 |
| Change In Payable | $1,468,000 | $1,624,000 | $2,371,000 | $-986,000 |
| Change In Account Payable | $337,000 | $965,000 | $1,143,000 | $220,000 |
| Change In Prepaid Assets | $-68,000 | $-519,000 | $201,000 | $1,296,000 |
| Other Non Cash Items | $-245,000 | $40,000 | $1,740,000 | $-1,325,000 |
| Stock Based Compensation | $10,617,000 | $9,916,000 | $7,926,000 | $6,748,000 |
| Depreciation Amortization Depletion | $1,232,000 | $1,102,000 | $1,074,000 | $979,000 |
| Depreciation And Amortization | $1,232,000 | $1,102,000 | $1,074,000 | $979,000 |
| Depreciation | $1,232,000 | $1,102,000 | $1,074,000 | $979,000 |
| Gain Loss On Investment Securities | $2,016,000 | $-259,000 | $-2,033,000 | $3,788,000 |
| Gain Loss On Sale Of PPE | $35,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $-42,627,000 | $-31,750,000 | $-29,157,000 | $-33,762,000 |
Fetched: 2026-06-19